{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Badepalle",
      "state": "N/A",
      "country": "India",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "86191",
      "recalling_firm": "Hetero Labs Limited (Unit V)",
      "address_1": "458 Surv No 439 - 441",
      "address_2": "Polepally Village",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to major wholesalers/distributors throughout the United States.",
      "recall_number": "D-1545-2020",
      "product_description": "Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India",
      "product_quantity": "43,512 bottles",
      "reason_for_recall": "Failed Tablet/Capsule Specification; complaint of bulging tablet",
      "recall_initiation_date": "20200806",
      "center_classification_date": "20200826",
      "termination_date": "20220124",
      "report_date": "20200902",
      "code_info": "Batch # LOA19357A, exp. date 09/2021"
    }
  ]
}